98%
921
2 minutes
20
Background: We aimed to investigate the effect of transforaminal injection of Magnesium sulphate versus Ozone on pain intensity, functional disability and the oxidative stress biomarkers; superoxide dismutase (SOD) and Glutathione (GSH) in patients with lumbar disc prolapse.
Methods: This randomized controlled trial was conducted on 135 patients having symptomatic lumbar disc prolapse, received either transforaminal injection of Magnesium sulphate with steroids, Ozone with steroids, or steroids alone. Assessment of pain severity and functional disability were done before intervention, 2 weeks, 1, 3, and 6 months after intervention. Serum SOD and GSH were measured for all included patients before and 2 weeks after intervention.
Results: There was a statistically significant improvement in pain intensity and functional disability 2 weeks after intervention in the three groups, but at 1-month and 3-months after intervention, the significant improvement was in Mg sulphate and Ozone groups only. At 6-months follow up, Mg sulphate group only showed a significant improvement. There was a statistically significant increase in SOD and GSH serum levels, 2-weeks after intervention in both Magnesium sulphate (P-value = 0.002, 0.005 respectively) and ozone groups (P-value < 0.001, < 0.001), but there was no statistically significant change in SOD and GSH serum levels in control group.
Conclusion: Transforaminal injection of Mg sulphate in patients with lumbar disc prolapse causes significant long-term improvement (up to 6 months) in pain intensity and functional disability. The serum levels of SOD and GSH were significantly increased at 2 weeks following both transforaminal injection of Mg sulphate and ozone.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358797 | PMC |
http://dx.doi.org/10.1186/s12871-022-01789-0 | DOI Listing |
Am J Phys Med Rehabil
September 2025
University of Rochester Medical Center, Department of Physical Medicine and Rehabilitation, 601 Elmwood Ave, Rochester, NY 14642.
Objective: The purpose of this study was to evaluate the effect of transforaminal epidural steroid injection (TFESIs) for patients with lumbosacral radiculopathy secondary to a lumbosacral herniated nucleus pulposus (HNP).
Design: A retrospective review of adult patients who received a fluoroscopically guided TSNRI for a HNP was performed. Patient Reported Outcome Measurement Information System (PROMIS) domains of Physical Function (PF), Pain Interference (PI), and Depression (D) were collected at baseline and post-procedure short-term (1-3 months post-procedure) and long-term follow-up (6-12 months post-procedure).
Interv Pain Med
September 2025
Columbia University, Vagelos College of Physicians and Surgeons, USA.
Interv Pain Med
September 2025
Division of PM&R, Department of Orthopaedic Surgery, Stanford University, 450 Broadway St., Redwood City, CA, USA.
Background: "Is this injection going to hurt?" Physicians typically answer this from experience since accurate answers are not available in the literature.
Objective: To quantify pain during common lumbosacral spine injections and compare to baseline pain prior to the injections. Analyze differences based on demographic and procedure variables.
Agri
July 2025
Department of Orthopedics, Baba Kinaram Government Medical College, Chandauli, India.
Objectives: Transforaminal lumbar epidural steroid injection (TFESI) has been used to treat lumbar radiculopathies. Erector spinae plane block (ESPB) has been employed to provide postoperative analgesia following spine and back surgeries. We aimed to compare TFESI with high-volume lumbar ESPB in patients with low backache and radicular pain.
View Article and Find Full Text PDFAgri
July 2025
Department of Anaesthesiology and Reanimation, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir, Türkiye.
Objectives: Low back pain is a widespread medical condition seen in middle-aged and elderly individuals, causing labor loss, high treatment costs, depression, and poor life quality. This study aimed to investigate pain levels, life quality, and depression in patients undergoing facet radiofrequency (RF) and/or transforaminal epidural steroid injection (TFESI) for the treatment of chronic low back pain (CLBP).
Methods: The records of 51 patients with low back pain lasting more than three months who underwent interventional procedures for pain management were reviewed retrospectively.